Market News Video
MNV MNV 10 Stocks Crossing Below Their 200 Day Moving Average
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Short Interest In United Therapeutics Declines 12.2%
Thursday, January 26, 1:17 PM ET, by Market News Video Staff

The most recent short interest data has been released for the 01/13/2017 settlement date, which ...

Notable ETF Inflow Detected - XBI, CLVS, ACAD, UTHR
Thursday, February 2, 10:46 AM ET, by Market News Video Staff

Symbols mentioned in this story: XBI, CLVS, ACAD, UTHR Exchange traded funds (ETFs) trade just ...

Notable Thursday Option Activity: OSIR, UTHR, FIZZ
Thursday, February 23, 11:33 AM ET, by Market News Video Staff

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy ...

Noteworthy Thursday Option Activity: SQBG, UTHR, SEAS
Thursday, March 2, 3:24 PM ET, by Market News Video Staff

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy ...

United Therapeutics Reaches Analyst Target Price
Monday, March 20, 9:20 AM ET, by Market News Video Staff

In recent trading, shares of United Therapeutics Corp (UTHR) have crossed above the average analyst ...

  More articles:  1 2 next »

Bullish Two Hundred Day Moving Average Cross - ANTH

By Market News Video Staff, Friday, October 21, 4:42 PM ET
Play Video: Learn About The 200 DMA

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Friday, shares of Anthera Pharmaceuticals Inc. (NASDAQ:ANTH) crossed above their 200 day moving average of $6.28, changing hands as high as $6.89 per share. Anthera Pharmaceuticals Inc. shares are currently trading up about 14.3% on the day. The chart below shows the one year performance of ANTH shares, versus its 200 day moving average:

Anthera Pharmaceuticals Inc. 200 Day Moving Average Chart

Looking at the chart above, ANTH's low point in its 52 week range is $3.65 per share, with $9.08 as the 52 week high point that compares with a last trade of $6.89.

ANTH operates in the Biotechnology sector, among companies like Cubist Pharmaceuticals Inc. (CBST) which is up about 1.1% today, and United Therapeutics Corp (NASDAQ:UTHR) trading up by about 0.1%. Below is a three month price history chart comparing the stock performance of ANTH, versus CBST and UTHR.

ANTH,CBST,UTHR Relative Performance Chart


The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.

Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   ANTH   Anthera   CBST   Crossing   Growth   Looking   Pharmaceuticals   Start   Stocks   Their   Therapeutics   Trial   UTHR   about   above   allows   asset   average   below   changing   chart   commodities   compares   currently   designed   flexibility   follow   high   history   level   month   moving   performance   point   portfolio   program   range   raquo   regions   sector   sectors   share   shares   that   trading   versus   week   wherever   which   with
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV MNV Chart Zero Stock Market Game Stock Market Definitions

Bullish Two Hundred Day Moving Average Cross - ANTH | Market News Video | Copyright © 2008 - 2017, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.